Maravai LifeSciences (MRVI) Social Stream



Maravai LifeSciences (MRVI): $28.45

0.49 (+1.75%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MRVI to Watchlist
Sign Up

Industry: Biotech


Ranked

of 396

in industry

Maravai Lifesciences Holdings Inc (MRVI) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering MRVI.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-19 8 $62 $32 $53.428 $35.27 51.48%
2021-11-11 8 $65 $32 $52.714 $35.27 49.46%
2022-01-23 6 $65 $49 $56.166 $35.27 59.25%
2022-02-08 6 $59 $42 $52.333 $35.27 48.38%
2022-02-24 6 $58 $42 $48.4 $35.27 37.23%

The Trend in the Analyst Price Target


MRVI's average price target has moved up $15.36 over the prior 14 months.

MRVI reports an average of 56.24% for its upside potential over the past 46 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-10 9 54 42 48.780 34.66 40.74%
2021-04-12 9 54 42 48.780 34.98 39.45%
2021-06-23 9 54 44 50.110 42.86 16.92%
2022-01-23 6 59 49 54.833 24.46 124.17%
2022-02-24 6 58 42 48.400 33.50 44.48%

MRVI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.08 5 1 0 0 0 6

The Trend in the Broker Recommendations


Over the past 123 days, MRVI's average broker recommendation rating improved by 0.08.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MRVI as an investment opportunity.

  • Maravai Lifesciences Holdings Inc's number of analysts covering the stock is higher than 121.44% of stocks in the large market cap category.
  • In terms of how Maravai Lifesciences Holdings Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 167.22% of that group.
  • Maravai Lifesciences Holdings Inc's average analyst price target is higher than 224.94% of stocks in the large market cap category.
  • MRVI has a lower variance in analysts' estimates than -233.11% of stocks in the large market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Maravai Lifesciences Holdings Inc are MRTX, JAZZ, and IONS.

What is the outlook for MRVI? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.0219 seconds.